Korsana Biosciences, Inc.
KRSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001755237
No open-market purchases or sales by Korsana Biosciences, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $11.2M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Korsana Biosciences, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 41 | 38 | −3 |
| Shares | 20.9M | 21.2M | +334.1K (+1.6%) |
| Value | $11.5M | $18.3M | +$6.79M (+59.2%) |
New holders (2)
Institutions that held Korsana Biosciences, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 10,651 | $9.00K | 0.00% |
| Goodman Advisory Group, LLC | 350 | $0 | 0.00% |
Sold out (5)
Institutions that held Korsana Biosciences, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Jane Street Group, LLC | 58,292 | $32.0K |
| Prudential Financial Inc | 52,270 | $29.0K |
| Davenport & Co LLC | 13,000 | $7.00K |
| High Net Worth Advisory Group LLC | 1,000 | $1.00K |
| Concord Wealth Partners | 10 | $0 |